VestGen Advisors’s Tenet Healthcare THC Stock Holding History

VestGen Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,469	Closed	-$484K	–	1156
2026 Q1	$484K	Buy	+2,469	New	+$520K	0.01%	671

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

VestGen Advisors's THC Position: Q2 2026 in Review

VestGen Advisors sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 2,469 shares — an estimated $484K sold.

VestGen Advisors first reported a position in THC in Q1 2026 and held it in 1 quarter. The position peaked at $484K in Q1 2026. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

VestGen Advisors reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
VestGen Advisors sold 2,469 Tenet Healthcare shares in Q2 2026, an estimated $484K.
VestGen Advisors first reported a position in Tenet Healthcare in Q1 2026 and held it in 1 quarter.
VestGen Advisors's Tenet Healthcare position peaked at $484K in Q1 2026.
679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.